Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-tumor vaccination].

V Schirrmacher1

  • 1Deutsches Krebsforschungszentrum, Heidelberg.

Zentralblatt Fur Chirurgie
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Optimal dosing of autologous Newcastle disease virus (NDV)-modified tumor vaccine significantly improved survival rates in breast cancer patients. Patients receiving optimal vaccine doses showed better overall and recurrence-free survival compared to those receiving suboptimal doses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gamma-irradiation suppresses T-cell mediated protective immunity against a metastatic tumor in the afferent phase of the immune-response but enhances it in the efferent phase when given before immune cell transfer.

International journal of oncology·2011
Same author

Expression of epidermal growth-factor receptor correlates with metastatic potential of 13762nf rat mammary adenocarcinoma cells.

International journal of oncology·2011
Same author

Adoptive transfer of protective immunity against a high metastatic tumor-cell variant by small numbers of tumor-specific in-situ activated peritoneal effector T-cells.

International journal of oncology·2011
Same author

Augmentation of protective immunotherapy against metastatic esb lymphoma-cells by combining immune cell transfer with host irradiation, antigen restimulation and/or anti-tnf-alpha antibody treatment.

International journal of oncology·2011
Same author

Effective immune rejection of advanced metastasized cancer.

International journal of oncology·2011
Same author

Peripheral immunization against malignant rat glioma can induce effective antitumor immunity in the brain.

International journal of oncology·2011

Area of Science:

  • Oncology
  • Immunotherapy
  • Vaccine Development

Background:

  • Breast cancer remains a significant global health challenge.
  • Adjuvant therapies are crucial for improving patient outcomes.
  • Novel immunotherapeutic approaches are under investigation.

Purpose of the Study:

  • To evaluate the efficacy of an autologous Newcastle disease virus (NDV)-modified tumor vaccine in primary operated breast cancer patients.
  • To compare survival outcomes between patients receiving optimal versus suboptimal vaccine doses.
  • To discuss the underlying mechanisms of this novel vaccine therapy.

Main Methods:

  • A cohort of 32 breast cancer patients received optimal dose autologous NDV-modified tumor vaccine postoperatively.
  • A comparable group of 31 patients received a suboptimal dose of the same vaccine.

Related Experiment Videos

  • Five-year survival rates, overall survival, and recurrence-free survival were analyzed.

    • Main Results:

    • Patients treated with the optimal dose vaccine demonstrated significantly better five-year overall survival rates.
    • Recurrence-free survival was also significantly improved in the optimal dose group.
    • The study highlights a dose-dependent response to the NDV-modified tumor vaccine.

    Conclusions:

    • Optimal dosing of autologous NDV-modified tumor vaccine is critical for maximizing survival benefits in breast cancer patients.
    • This vaccine represents a promising immunotherapeutic strategy for adjuvant breast cancer treatment.
    • Further research into the vaccine's mechanism of action and broader clinical application is warranted.